Telix Pharmaceuticals Limited (TLX)

NASDAQ: TLX · Real-Time Price · USD

11.45

+0.60 (5.53%)

At close: Sep 2, 2026, 4:00 PM EDT

11.99

+0.54 (4.72%)

Pre-market: Sep 3, 2026, 6:15 AM EDT

Telix Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,823	2,530	5,098	2,223	1,563	1,606
Market Cap Growth	15.70%	-50.36%	129.30%	42.23%	-2.70%	96.45%
Enterprise Value	4,163	2,745	5,038	2,142	1,482	1,572
Last Close Price	11.45	7.49	15.40	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	114.14	-	151.34	528.32	-	-
PS Ratio	4.29	3.15	9.87	6.68	14.37	290.85
PB Ratio	7.84	6.09	14.44	21.66	28.75	1023.78
P/TBV Ratio	-	-	53.62	80.58	109.40	-
P/FCF Ratio	-	-	277.46	279.08	-	-
P/OCF Ratio	-	-	185.44	155.76	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	4.67	3.42	9.75	6.43	13.62	284.54
EV/EBITDA Ratio	59.64	84.57	84.48	56.13	-	-
EV/EBIT Ratio	75.34	142.34	90.15	61.25	-	-
EV/FCF Ratio	-	-	274.21	268.94	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	1.19	1.13	1.02	0.12	0.13	1.18
Debt / EBITDA Ratio	7.47	11.61	5.89	0.31	-	-
Debt / FCF Ratio	-	-	19.60	1.54	-	-
Net Debt / Equity Ratio	0.67	0.78	-0.23	-0.70	-1.32	-9.03
Net Debt / EBITDA Ratio	4.70	10.02	-1.34	-1.89	1.52	0.25
Net Debt / FCF Ratio	-7.21	-7.57	-4.34	-9.04	1.49	0.32
Asset Turnover	0.70	0.76	0.85	1.48	0.88	0.06
Inventory Turnover	12.58	13.90	10.84	14.01	10.92	1.25
Quick Ratio	1.74	1.21	2.63	1.20	1.90	1.13
Current Ratio	2.01	1.43	2.78	1.43	2.03	1.25
Return on Equity (ROE)	7.36%	-1.85%	14.79%	5.36%	-253.34%	-198.36%
Return on Assets (ROA)	2.71%	1.15%	5.74%	9.69%	-25.37%	-37.95%
Return on Invested Capital (ROIC)	6.78%	3.81%	32.69%	537.03%	-	-
Return on Capital Employed (ROCE)	4.90%	2.10%	7.60%	21.10%	-43.60%	-113.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	0.88%	-0.28%	0.66%	0.19%	-4.53%	-3.64%
FCF Yield	-1.19%	-1.70%	0.36%	0.36%	-3.09%	-2.75%
Buyback Yield / Dilution	-2.75%	2.12%	-6.64%	-4.21%	-10.08%	-9.69%

SEC Filings: 10-K · 10-Q